Reata stocktwits
Webb14 apr. 2024 · Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) – Analysts at SVB Leerink dropped their Q1 2024 earnings estimates for Reata Pharmaceuticals in a report issued on Tuesday, April 11th. Webb5 apr. 2024 · 6 analysts have issued twelve-month price objectives for Reata Pharmaceuticals' stock. Their RETA share price forecasts range from $67.00 to $138.00. …
Reata stocktwits
Did you know?
WebbRealETA (@RealETA) Stocktwits More 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. RealETA RealETA Follow Strategy: Equities Options … WebbThe latest messages and market ideas from Riata (@reborn12) on Stocktwits. The largest community for investors and traders
WebbReata Pharmaceuticals (RETA) Latest Stock News - STCK.PRO Reata Pharmaceuticals (RETA) More RETA news SYNC WITH STOCKTWITS Get all the latest news for all your … Webb13 apr. 2024 · Reata Pharmaceuticals (NASDAQ:RETA) has a recorded annual revenue of $2.22 million. How much profit does Reata Pharmaceuticals generate each year? Reata Pharmaceuticals (NASDAQ:RETA) has a recorded net income of -$311.90 million. RETA has generated -$8.56 earnings per share over the last four quarters.
Webb14 apr. 2024 · Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits. Analysts at StockNews.com began coverage on shares of Profire ... Q1 2024 Earnings Estimate for Reata Pharmaceuticals, Inc Webb14 apr. 2024 · The stock has a market capitalization of C$54.11 billion, a P/E ratio of -87.19, a P/E/G ratio of 0.78 and a beta of 0.32. Newmont has a 12 month low of C$51.44 and a 12 month high of C$108.98. The...
WebbReata Pharmaceuticals Inc Follow Share $93.98 After Hours: $94.00 (0.021%) +0.020 Closed: Apr 6, 4:49:07 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to BridgeBio Pharma Inc $15.61...
Webb10 apr. 2024 · RETA Stock Overview Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. About the company Rewards Earnings are forecast to grow 59.16% per year Risk Analysis Highly volatile share price over the … nuk 5 pacifier speech therapyWebb1 mars 2024 · 74,000: Signatories on a petition created by the Friedreich’s Ataxia Research Alliance (FARA), urging Reata to seek the treatment’s approval and for the FDA to consider its merit. $400 million ... ninja professional 9-cup food processorWebbStockTwits sells its feed in several different ways: hedge funds and other money managers pay for access to its data. Media companies like Bloomberg, Reuters and Yahoo Finance draw on the StockTwits feed for real time opinion and context on news. ninja professional 72oz countertop blenderWebbFind the latest Reata Pharmaceuticals, Inc. (RETA) stock quote, history, news and other vital information to help you with your stock trading and investing. nuk 618 months pacifierWebb14 apr. 2024 · Reata Pharmaceuticals (NASDAQ:RETA – Get Rating) had its price target boosted by Stifel Nicolaus from $105.00 to $115.00 in a report issued on Thursday morning, The Fly reports.A number of other research firms have also commented on RETA. The Goldman Sachs Group lifted their price target on shares of Reata Pharmaceuticals … nuk 5 pacifier walmartWebb11 juni 2024 · reata’s cash guidance updated: runway extended through end of 2024. reata to host conference call on june 11, 2024 at 8:30 am et. new york and plano, texas, june 11, 2024 (globe newswire) -- ... nuk 6 month sippy cupWebb8 okt. 2024 · Virgin Galactic Holdings, Inc. (SPCE) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 3.4985 +0.3485 (+11.06%) As of 11:28AM EDT. Market open. Summary Company Insights Chart... nuk 5 pacifier website